Context: We have previously reported that benznidazole (BZL), known for its trypanocidal action, has anti-proliferative activity against different cell lines like HeLa and Raw 264.7 among others. At the moment, it has not been reported if the anti-proliferative effect of BZL is similar for non-adherent hematopoietic cells like was reported for adherent cancer cell lines. Objective: We aimed to investigate the efficacy of BZL on the growth of the leukemic cell lines THP-1 and OCI/AML3. Materials and methods: We evaluated cell proliferation by [(3)H]-thymidine incorporation and MTT reduction as well as cell death by lactate dehydrogenase (LDH) activity. We assessed apoptosis by flow cytometry for detection of annexin V-positive and propidium ...
Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins...
Background and Aim: A goal of modern cancer research is to reach targeted therapies with drugs havin...
<p><strong><em>Background and Objectives:</em></strong> This study aim...
PURPOSE: Dasatinib is a dual Src/Abl inhibitor recently approved for Bcr-Abl+ leukemias with resista...
Introduction: Cancer is the second leading cause of death in the world and among the types of cancer...
<div><p>Acute myeloid leukemia (AML) is the most common malignant myeloid disorder of progenitor cel...
Aims: We evaluated biological activity in leukemia cells lines of R and S enantiomers of tert-butyl ...
Background: Adult T-cell leukemia/lymphoma (ATLL) is a poor prognostic Hematopoietic malignancy with...
Purpose: Inhibition of the antiapoptotic BCL2 family is one of the most promising areas of anticance...
[Purpose]: To analyze the antimyeloma potential of TG02, an ERK5/CDK inhibitory drug. [Experimental ...
Objective: Cancer is one of the major causes of death worldwide irrespective of the sex. The aim of ...
Purpose: The aim of this study was to investigate the effects of a chemotherapeutic agent Cytosine A...
Background: The management of Philadelphia Chromosome-positive (Ph+) hematological malignancies is s...
Bcl-2, an anti-apoptotic protein, is a well-known and appealing cancer therapy target. Novel series ...
Deregulation of Nuclear Transcription Factor-kB (NF-kB) and Jun N-terminal kinase (JNK) signaling is...
Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins...
Background and Aim: A goal of modern cancer research is to reach targeted therapies with drugs havin...
<p><strong><em>Background and Objectives:</em></strong> This study aim...
PURPOSE: Dasatinib is a dual Src/Abl inhibitor recently approved for Bcr-Abl+ leukemias with resista...
Introduction: Cancer is the second leading cause of death in the world and among the types of cancer...
<div><p>Acute myeloid leukemia (AML) is the most common malignant myeloid disorder of progenitor cel...
Aims: We evaluated biological activity in leukemia cells lines of R and S enantiomers of tert-butyl ...
Background: Adult T-cell leukemia/lymphoma (ATLL) is a poor prognostic Hematopoietic malignancy with...
Purpose: Inhibition of the antiapoptotic BCL2 family is one of the most promising areas of anticance...
[Purpose]: To analyze the antimyeloma potential of TG02, an ERK5/CDK inhibitory drug. [Experimental ...
Objective: Cancer is one of the major causes of death worldwide irrespective of the sex. The aim of ...
Purpose: The aim of this study was to investigate the effects of a chemotherapeutic agent Cytosine A...
Background: The management of Philadelphia Chromosome-positive (Ph+) hematological malignancies is s...
Bcl-2, an anti-apoptotic protein, is a well-known and appealing cancer therapy target. Novel series ...
Deregulation of Nuclear Transcription Factor-kB (NF-kB) and Jun N-terminal kinase (JNK) signaling is...
Fluorizoline is a new synthetic molecule that induces apoptosis by selectively targeting prohibitins...
Background and Aim: A goal of modern cancer research is to reach targeted therapies with drugs havin...
<p><strong><em>Background and Objectives:</em></strong> This study aim...